Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Pautas

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Soins. Gerontologie|September 16, 2023
[Proper use of oral anticoagulants in the elderly patient]Eric Pautas
La Revue Du Praticien|January 12, 2010
[Risk and management of anti-vitamin K in the elderly]Eric Pautas
Current Opinion in Pulmonary Medicine|August 19, 2004
Low molecular weight heparin treatment in elderly subjects with or without renal insufficiency: new insights between June 2002 and March 2004Virginie Siguret, Eric Pautas, Isabelle Gouin
Future Cardiology|October 7, 2009
Vitamin K antagonist use in the elderly: special considerationsVirginie Siguret, Eric Pautas, Isabelle Gouin-Thibault
Clinical Interventions in Aging|May 12, 2010
A need for evidence-based clinical practice guidelines for the use of heparins in the elderlyIsabelle Gouin-Thibault, Virginie Siguret, Eric Pautas
Drug Safety|March 24, 2005
Safety profile of different low-molecular weight heparins used at therapeutic doseIsabelle Gouin-Thibault, Eric Pautas, Virginie Siguret
Vitamins and Hormones|April 1, 2008
Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarinVirginie Siguret, Eric Pautas, Isabelle Gouin-Thibault
Soins. Gerontologie|January 21, 2014
[Management of oral anticoagulants by elderly patients at home]Eric Pautas, Charlotte Naline, Jean-Louis Golmard, et al.
Drugs & Aging|July 26, 2013
Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderlyVirginie Siguret, Isabelle Gouin-Thibault, Pascale Gaussem, et al.
Drugs & Aging|February 24, 2006
Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and managementEric Pautas, Isabelle Gouin-Thibault, Matthieu Debray, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Soins. Gerontologie|September 16, 2023
[Proper use of oral anticoagulants in the elderly patient]Eric Pautas
La Revue Du Praticien|January 12, 2010
[Risk and management of anti-vitamin K in the elderly]Eric Pautas
Current Opinion in Pulmonary Medicine|August 19, 2004
Low molecular weight heparin treatment in elderly subjects with or without renal insufficiency: new insights between June 2002 and March 2004Virginie Siguret, Eric Pautas, Isabelle Gouin
Future Cardiology|October 7, 2009
Vitamin K antagonist use in the elderly: special considerationsVirginie Siguret, Eric Pautas, Isabelle Gouin-Thibault
Clinical Interventions in Aging|May 12, 2010
A need for evidence-based clinical practice guidelines for the use of heparins in the elderlyIsabelle Gouin-Thibault, Virginie Siguret, Eric Pautas
Drug Safety|March 24, 2005
Safety profile of different low-molecular weight heparins used at therapeutic doseIsabelle Gouin-Thibault, Eric Pautas, Virginie Siguret
Vitamins and Hormones|April 1, 2008
Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarinVirginie Siguret, Eric Pautas, Isabelle Gouin-Thibault
Soins. Gerontologie|January 21, 2014
[Management of oral anticoagulants by elderly patients at home]Eric Pautas, Charlotte Naline, Jean-Louis Golmard, et al.
Drugs & Aging|July 26, 2013
Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderlyVirginie Siguret, Isabelle Gouin-Thibault, Pascale Gaussem, et al.
Drugs & Aging|February 24, 2006
Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and managementEric Pautas, Isabelle Gouin-Thibault, Matthieu Debray, et al.
Pageof 5